Marathon performance but not BMI affects post-marathon pro-inflammatory and cartilage biomarkers by Mündermann, Annegret et al.
 1 
Marathon performance but not BMI affects post-marathon 
pro-inflammatory and cartilage biomarkers 
 
Annegret Mündermann, Ph.D.a 
Jeroen Geurts, Ph.D.a 
Thomas Hügle, M.D./Ph.D.a 
Thomas Nickel, M.D./Ph.D.b 
Arno Schmidt-Trucksäss, M.D.c 
1Martin Halle, M.D.d,e,f 
1Henner Hanssen, M.D.c,d 
 
aClinic for Orthopaedics and Traumatology, University Hospital Basel, Switzerland 
bMedizinische Klinik und Poliklinik 1, Campus Grosshadern, Ludwig-Maximilians-
Universität München, Munich, Germany 
cDepartment of Sport, Exercise and Health, University of Basel, Switzerland 
dDepartment of Prevention and Sports Medicine, Technische Universität München, 
Germany 
eDeutsches Zentrum für Herz-Kreislauf-Forschung (DZHK), partner site Munich Heart 
Alliance, Munich, Germany 
fElse Kröner-Fresenius-Zentrum, Klinikum rechts der Isar, Technische Universität 
München, Munich, Germany 
 
Original Investigation 
 
This is an Accepted Manuscript of an article published by Taylor & Francis in Journal of 
Sports Sciences on May 11 2016, available online 
http://dx.doi.org/10.1080/02640414.2016.1184301. 
 
Address for correspondence: PD Dr. Annegret Mündermann 
Clinic for Orthopaedics and Traumatology 
University Hospital Basel 
Spitalstrasse 21 
4031 Basel, Switzerland 
Tel. +41 61 265 94 44 
Email annegret.muendermann@unibas.ch 
 
Word count: 3,221 words 
 
Running title: Marathon performance, BMI and biomarkers 
 
Key words: cartilage biomarkers, tissue metabolism, marathon running, pro-
inflammatory markers, obesity 
 
Acknowledgements: The authors thank Immunodiagnostic Systems for providing the 
COMP ELISA kits. The sponsor did not have a role in any aspect of this study. 
  
                                                
1 Martin Halle and Henner Hanssen share senior authorship. 
 2 
 
ABSTRACT 
We tested the hypothesis that changes in serum cartilage oligomeric matrix protein 
(COMP), tumor-necrosis factor α (TNF-α), interleukin-6 (IL-6) and high-sensitivity C-
reactive protein (hsCRP) concentration after regular endurance training and running a 
marathon race depend on body mass index (BMI) and/or on marathon performance. 
Blood samples were collected from 45 runners of varying BMI and running experience 
before and after a 10-week marathon training program and before, immediately and 24 
hours after a marathon race. Serum biomarker concentrations, BMI and marathon 
finishing time were measured. The mean (95% confidence interval (CI)) changes from 
before to immediately after the marathon were: COMP: 4.09U/L (3.39–4.79U/L); TNF-
α: -1.17mg/L (-2.58–0.25mg/L); IL-6: 12.0pg/mL (11.4–12.5pg/mL); and hsCRP: -
0.08pg/mL (-0.14–-0.3pg/mL). The mean (95% CI) changes from immediately after to 
24 hours after the marathon were: COMP: 0.35U/L (-0.88–1.57U/L); TNF-α: -0.43mg/L 
(-0.99–0.13mg/L); IL-6: -9.9pg/mL (-10.5–-9.4pg/mL); and hsCRP: 1.52pg/mL (1.25–
1.79pg/mL). BMI did not affect changes in biomarker concentrations. Differences in 
marathon finishing time explained 32% of variability in changes in serum hsCRP and 
28% of variability in changes in serum COMP during the 24-hour recovery after the 
marathon race (P<0.001). Slower marathon finishing time but not a higher BMI 
modulates increases in pro-inflammatory markers or cartilage markers following a 
marathon race. 
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INTRODUCTION 
In recent years, marathon running has become increasingly popular with more 
than 700 races worldwide and up to 50’000 participants per event (Schiffer, Montiel, 
Hildebrandt, Predel, & Knackstedt, 2010). These events attract participants with diverse 
athletic backgrounds from elite runners to novices and different body compositions 
ranging from lean to obese participants (Vadeboncoeur et al., 2012). However, until 
recently, the health implications of larger body mass index (BMI) in long distance 
running have received little attention. 
Being obese (defined as BMI > 30 kg/m2) or overweight (25 < BMI ≤ 30 kg/m2) 
represents a greater demand for the cardiovascular system and has been associated with 
a greater risk for cardiovascular disease (Despres, 2012) and subclinical inflammation 
(Hsieh, Wang, & Chen, 2014), which can lead to insulin resistance and metabolic 
syndrome (Bastard et al., 2006). Elevated plasma concentrations of pro-inflammatory 
cytokines (including tumor-necrosis-factor alpha (TNF-α) and interleukin-6 (IL-6)) and 
high-sensitivity C-reactive protein (hsCRP) are typical for obese persons (Kasapis & 
Thompson, 2005). Aerobic exercise in active obese persons modulates the immune 
system response, increases inflammatory resistance, and mediates cardiovascular 
protection (Nickel et al., 2011) with an immediate increase in IL-6 and IL-10 levels and 
a delayed increase in TNF-α and CRP-levels after a marathon run (Nickel, Emslander, 
et al., 2012). Hence, regular exercise training as well as acute bouts of exercise affect 
inflammatory markers. Moreover, inflammation plays a role in the pathomechanics of 
osteoarthritis (OA) in obese persons (Andriacchi et al., 2004). 
Serum concentrations of cartilage biomarkers are frequently used as surrogates 
for cartilage turnover, and these concentrations respond to physiological load. For 
instance, serum concentrations of cartilage oligomeric matrix protein (COMP) increase 
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after exercise bouts of walking (Mündermann, Dyrby, Andriacchi, & King, 2005; 
Mündermann, King, Smith, & Andriacchi, 2009; Pruksakorn et al., 2013), running 
(Kersting, Stubendorff, Schmidt, & Bruggemann, 2005; Niehoff et al., 2010; Niehoff et 
al., 2011) and marathon running (Neidhart et al., 2000) but not after deep knee bends 
(Niehoff et al., 2010). Hence, load-induced changes in COMP appear to be sensitive to 
load magnitude. Serum COMP has been associated with the incidence of knee OA 
(Saberi Hosnijeh, Runhaar, van Meurs, & Bierma-Zeinstra, 2015), and load-induced 
changes in serum COMP predict changes in cartilage thickness in patients with knee 
OA (Erhart-Hledik et al., 2012). However, the prevalence of knee osteoarthritis in 
former elite marathon runners is not higher than that in the general population (Schmitt, 
Rohs, Schneider, & Clarius, 2006). In contrast, greater joint loads have been identified 
as factor involved in the greater prevalence of knee OA in obese persons (Vincent, 
Heywood, Connelly, & Hurley, 2012), and obese persons ambulate with altered joint 
mechanics compared to normal-weight persons (Messier et al., 2014; Runhaar, Koes, 
Clockaerts, & Bierma-Zeinstra, 2011). These ambulatory differences may contribute to 
an earlier initiation of osteoarthritic changes in obese persons (Andriacchi & 
Mündermann, 2006). To date the effect of regular endurance training compared to acute 
marathon running on cartilage biomarkers in overweight or obese athletes has not been 
investigated. 
Weight loss in combination with increased physical activity, a negative energy 
balance, and diet adjustment has been associated with lower inflammation and 
consequently with lower cardiovascular risk factors in obese persons (Petelin et al., 
2014) and resulted in lower serum COMP (Bartels et al., 2014). Moreover, exercise 
training programs lead to reductions in serum COMP in healthy persons (Celik, Salci, 
Ak, Kalaci, & Korkusuz, 2013). However, a potential modulating effect of 
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inflammation on load-induced changes in serum COMP in normal-weight and obese 
experienced and novice runners has not been investigated. 
The purpose of this study was to test if changes in serum COMP, TNF-α, IL-6 
and hsCRP concentration in response to regular endurance training and running a 
marathon race depend on BMI and/or on marathon performance. 
 
METHODS 
Participants 
Forty-five male runners were included in this observational substudy of a 
previously published intervention study (Nickel, Emslander, et al., 2012; Nickel et al., 
2011; Nickel, Vogeser, et al., 2012) (clinicaltrials.gov identifier: NCT00500773). 
Briefly, participants were recruited from a group of runners with varying BMI and 
previous running experience (Table 1) undergoing 10-week running training before 
completing a marathon race. All participants provided informed written consent prior to 
participation. The original study was conducted in 2007 in Munich (Germany). The 
study was approved by the institutional ethics committee and conducted in accordance 
with the Declaration of Helsinki. Only healthy male runners aged 30–60 years without 
any cardiovascular risk factor other than weight were included. Other exclusion criteria 
were known coronary or structural heart disease, insulin-dependent diabetes mellitus, 
drug treatment for type 2 diabetes or hypertension, hyperlipoproteinemia, renal 
dysfunction, chronic inflammation, and musculoskeletal disorder. 
 
Study protocol 
Anthropometric measurements including body fat composition (caliper 
measurement) and fasting (overnight) blood samples were taken 2 to 5 days before and 
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after a 10-week running endurance training program (Figure 1). The training program 
was scheduled for the 10-weeks immediately preceding the marathon race so that the 
blood sample at the end of the training period was taken 2 days before the marathon. 
Participants fasted before blood sampling and avoided acute bouts of exercise 2 days 
prior to the examination. Additional blood samples were taken immediately after and 24 
hours after the marathon race. 
 
Endurance training protocol 
The 10-week running endurance training comprised continuous aerobic and 
interval training including warm-up and cool-down periods with a gradual increase in 
duration and intensity during the course of the 10-week training program. An individual 
training program for each participant was prescribed with regard to current fitness levels. 
The intensity of the training was given by individual target heart rates monitored by 
heart rate monitors. Supervised exercise training was offered four times per week under 
medical supervision. Training was documented with respect to intensity, duration, and 
kilometres run per week by a written protocol. 
 
IL-6, TNF-α, hsCRP and COMP 
Blood was collected and allowed to clot for 30 min. Sera were separated and 
frozen to -20°C within 1 hour of collection and then transferred for storage at -80°C 
until assayed. Samples were defrosted and IL-6, TNF-α, hsCRP and COMP levels were 
examined using cytokine- and protein-specific ELISA kits according to the 
manufacturers’ instructions (IL-6: Bender Med-Systems, Austria; TNF-α: Biosource, 
USA; hsCRP: Biosource, USA; COMP: Anamar, Sweden). All samples of each 
participant were tested on the same plate to preclude the effect of inter-assay variability. 
 7 
All samples were tested in duplicates, and the intra-assay and inter-assay coefficients of 
variation were ≤5%. 
 
Statistical analysis 
All statistical analyses were performed in SPSS version 22.0 (IBM Corporation, 
Armonk, NY). Normal distribution of data were confirmed using Kolmogorov Smirnov 
tests. Changes in demographics between time points were detected using analysis of 
variance for repeated measures (P<0.05) with Student t-test for dependent measures as 
posthoc tests with Bonferroni correction (P<0.01). Linear mixed models were used to 
detect significant changes in serum biomarker concentrations over time with covariates 
BMI and marathon finishing time (P<0.05). Posthoc comparisons were performed using 
Student t-test for dependent measures with Bonferroni correction (P<0.006). Stepwise 
linear regression models were used to detect the effects of BMI and marathon finishing 
times on changes in serum biomarkers from before to after and from immediately after 
to 24 hours after the marathon race (P<0.05). Participants were grouped into tertile 
groups based on their marathon finishing time. Differences in changes in biomarkers 
between tertile groups were detected using linear mixed models with tertile group as 
between-subject factor and time as within-subject factor (P<0.05). 
 
RESULTS 
On average, participants ran between 12 and 78 km per week during the 10-
week endurance running training (Table 1). While only small but significant reductions 
in body mass, BMI and waist circumference were observed (-1.6%, -2.0% and -2.1%; 
P<0.001), body fat was 11.0% lower after the 10-week endurance training period 
compared to baseline (P<0.001; Table 1). BMI ranged from 17.0 to 36.5 kg/m2. Overall, 
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1, 24, 16 and 4 participants were classified as underweight (BMI ≤ 20 kg/m2), normal 
(20 < BMI ≤ 25 kg/m2), overweight (25 < BMI ≤ 30 kg/m2) and obese (BMI > 30 
kg/m2), respectively. Marathon finishing time ranged from 2:56 to 5:32 hours (Table 1). 
Differences in serum concentrations between time points were observed for IL-6, 
hsCRP and COMP (P<0.005) but not for TNF-α (P=0.88; results of generalized linear 
models; Table 2). Serum IL-6 showed an elevenfold increase during the marathon race 
and decreased to 2.8 times the baseline level within 24 hours after the marathon race 
(Figure 2). Serum hsCRP showed small but significant changes during the training and 
marathon race and a more than hundredfold increase in the 24 hours after the marathon 
race (Figure 3). Serum COMP increased by 39% during the marathon race and 
remained elevated 24 hours after the marathon race. The variability in all serum 
concentrations was greater 24 hours after the marathon than at all other time points 
(except for TNF-α at baseline; Figures 2 and 3). 
BMI did not affect changes in serum in IL-6, TNF-α, hsCRP and COMP 
(P>0.75). Differences in marathon finishing time explained 32% of variability in 
changes in serum hsCRP and 28% of variability in changes in serum COMP during the 
24-hour recovery after the marathon race (P<0.001; Table 3). Runners were grouped 
into tertile groups by marathon finishing time (Table 1). The slowest third based on 
marathon finishing time had the greatest increase in hsCRP and a further increase in 
COMP 24 hours after the marathon race while the fastest third had the smallest increase 
in hsCRP and the largest decrease in COMP 24 hours after the marathon race (Figure 4). 
Changes in IL-6 and TNF-α did not correlate with marathon finishing time (R2<.04). 
While the required sample size was not calculated a priori because this study was a sub-
analysis of a study on cardiovascular factors, posthoc analyses revealed that all statistically 
significant results in this study had a power above 80% 
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DISCUSSION 
The purpose of this study was to determine the interrelation between changes in 
serum COMP, TNF-α, IL-6 and hsCRP concentration in response to regular endurance 
training and running a marathon race depending on BMI and/or on marathon 
performance. Serum COMP and IL-6 increased immediately after while hsCRP and – 
although not significantly – TNF-α concentrations increased 24 hours after running a 
marathon. BMI was not related to these changes during training and immediately and 24 
hours after the marathon race. In contrast, changes in hsCRP and COMP within 24 
hours after the marathon race depended on marathon finishing time. These results 
provide first evidence that the inflammatory and cartilage responses to marathon 
running do not depend on BMI but on marathon performance. 
 
BMI and biomarkers 
Contrary to our hypothesis, BMI did not affect the response of the biomarkers 
tested in this study. Moreover, including body fat, waist circumference and hip 
circumference in our linear regression model (results not reported) did not affect the 
results. Several benefits of running on general health have been reported. For instance, 
running programs result in weight loss and decrease in diastolic blood pressure in obese 
persons (Schjerve et al., 2008), and exercise-induced improvement in microvascular 
function in obese runners has been previously demonstrated (Hanssen et al., 2011). 
Moreover, running more than 63 km per week on average substantially diminishes the 
risk for inherited obesity (Williams, 2012). 
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Marathon finishing time and biomarkers 
Pro-inflammatory biomarkers 
IL-6 is a pro-inflammatory cytokine secreted by T-cells and macrophages and is 
released by skeletal muscles in response to endurance exercise. In this study, serum 
concentrations of IL-6 were elevated immediately after the marathon race and returned 
to close to baseline levels within 24 hours after the marathon in all runners indicating a 
recovery of muscle metabolism within 24 hours after the marathon race independent of 
marathon finishing time. This result is in agreement with the literature (Neidhart et al., 
1997). TNF-α is a cytokine and mediator of systemic inflammation and involved in 
acute phase reactions. In contrast to IL-6, TNF-α levels increased within 24 hours after 
the marathon race in most runners. Neidhardt et al. (Neidhart et al., 1997) reported an 
increase in TNF-α during a marathon race that remained elevated up to 24 hours after 
the race. These results suggest an inflammatory response that is independent of muscle 
load experienced during the marathon race. Interestingly and contrary to previous 
reports (Kasapis & Thompson, 2005), IL-6 and TNF-α levels were not related to BMI in 
our study. In this study, we only included runners without any cardiovascular risk factor 
other than weight and without clinical inflammation. Hence, BMI does not have a 
modulating effect on serum biomarkers, and elevated levels of pro-inflammatory 
cytokines may not be related primarily to BMI but to other factors associated with 
obesity. 
Increased release of IL-6 induces hepatic glucose generation and lipolysis, and 
IL-6 has been shown to link skeletal muscles contraction with exercise-induced 
metabolic needs (Pedersen et al., 2001). IL-6 inhibits the release of TNF-α explaining 
the latter’s delayed – albeit not significant – increase 24 hours after the marathon race. 
Moreover, hsCRP is produced in the liver following IL-6 secretion from macrophages 
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and T-cells. The half-life of hsCRP of 48 hours is constant, and therefore its level is 
determined by the rate of production and hence the severity of the precipitating cause. 
hsCRP is a marker for inflammation and for future cardiovascular events. We have 
shown that hsCRP is elevated after a marathon race – similar to those reported by Kim 
et al. (Kim, Lee, & Kim, 2009) – independent of BMI. However, the increase in hsCRP 
in our study (+1.5mg/ml) was smaller than that reported by Greene et al. (Greene, 
Martin, & Crouse, 2012) (+5.0 mg/ml) who reported elevated hsCRP in overweight and 
obese persons 24 hours after acute exercise regardless of training. Nonetheless, hsCRP 
in some participants exceeded values considered as risk factor for cardiovascular 
disease (above 3.0 mg/L (Ridker & Libby, 2007)) 24 hours after the marathon race. Our 
results showed that the effect of a marathon race on hsCRP differs largely among 
runners, and that the magnitude of changes in hsCRP seems to depend on marathon 
finishing time. 
 
Cartilage biomarkers 
Serum COMP has been associated with the incidence of knee OA (Saberi 
Hosnijeh et al., 2015). Immediately and 24 hours after the marathon race, more than 
half of our participants had values above 15 U/L previously related to a high risk of 
aggressive joint destruction (Andersson et al., 2013). Increases in COMP in this study 
were greater than those reported for shorter running exercises (Denning et al., 2014; 
Kersting et al., 2005; Niehoff et al., 2010; Niehoff et al., 2011) and comparable to 
observed changes after marathon races (Kim et al., 2009; Neidhart et al., 2000). In 
contrast to a previous study (Neidhart et al., 2000), COMP concentrations did not return 
to baseline within 24 hours after the marathon in all runners. This discrepancy may be 
explained by difference in study cohorts where we included runners with a larger 
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variability in BMI and in running performance than previous studies. Compared to the 
other biomarkers assessed in this study, COMP showed the largest variability at any 
time point and in changes over time. This result suggests that several factors influence 
serum COMP. 
 
Marathon finishing time, pro-inflammatory and cartilage biomarkers 
Marathon finishing time predicted changes in serum biomarkers during the 24-
hour recovery after the marathon. Moreover, marathon finishing time mediated the 
relationship between changes in hsCRP and COMP (Figure 4). These finishing time-
related changes may represent differences in post-stress tissue metabolism between 
participants. There are several possible explanations for these differences. For instance, 
a marathon race may represent a greater relative load compared to that experienced 
during a typical training week requiring longer recovery time as previously reported for 
longer running races (Kim et al., 2009). While including weekly mileage in our linear 
regression models did not affect the results, this possibility is further supported by the 
fact that slower runners will perform more gait cycles to cover the 42-km distance than 
faster runners because of the small variability in stride frequency at different running 
speeds (Hay, 2002) and between slow and fast runners throughout a marathon (Chan-
Roper, Hunter, J, D, & M, 2012). At an assumed stride frequency of 1.42 strides/s, 
runners in the fast third performed fewer than 19,425 strides compared to at least 22,237 
steps in the slow third. Faster runners also experience greater shock absorption (Mercer, 
Devita, Derrick, & Bates, 2003) although this fact may not be directly related to the 
load applied at the cartilage-cartilage interface at the knee because of the greater muscle 
forces necessary for stabilizing the knee at greater knee flexion angles during faster 
running (Chan-Roper et al., 2012). In addition, it is possible that the tissue metabolism 
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differs between athletes varying in fitness. However, including fitness in our linear 
regression model (results not reported) did not affect the results. Interestingly, 
Vuolteenaho et al. (Vuolteenaho, Leppanen, Kekkonen, Korpela, & Moilanen, 2014) 
found no changes in COMP after a marathon race but reported that observed increases 
in matrix metalloproteinases 3 (MMP-3) immediately after the marathon correlated 
negatively with marathon finishing time. A potential role of MMP-3 in exercise-induced 
changes in COMP was not investigated in our study. 
The increase in COMP and hsCRP levels after marathon may suggest a role of 
inflammatory processes in stress-induced cartilage metabolism during recovery. The 
inflammatory potential of marathon running as previously shown (Nickel, Emslander, et 
al., 2012) may influence tissue metabolism and may hence be an important factor for 
long-term effects of marathon running. Because COMP lacks the ability to trigger a pro-
inflammatory response in chondrocytes (Ruthard et al., 2014), increased serum COMP 
in slower runners may rather result from than cause the greater release of hsCRP in 
these participants. We included only runners without any preclinical inflammation. It is 
possible that the observed exercise-induced inflammatory response may be even more 
pronounced in patients with preclinical inflammation. 
 
Study limitations 
The limitations of this study include the size of the study cohort and selection of 
participants for this study. The fastest marathon finishing time in our study was just 
under 3 hours. Hence, none of the runners were top athletes. The finishing time groups 
were defined by tertiles of overall finishing times (fast < 3:48 hours < middle < 4:21 
hours < slow) rather than by predefined performance parameters. The relationships 
reported in this study may thus not be readily extrapolated to runners outside of the 
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reported time ranges. Similarly, including more runners with an even larger range of 
BMI might influence the results of the statistical analyses. Moreover, we only included 
selected markers for inflammation and cartilage health, and these markers do not 
provide sufficient explanation of potential mechanisms. We did not quantify the number 
of loading cycles or the load magnitude in these runners. It is possible that including 
these parameters would provide additional insight into the relationship between 
marathon finishing time and post-marathon changes in biomarkers. 
 
Conclusions 
We showed that higher BMI alone does not lead to greater increases in pro-
inflammatory markers or cartilage markers following a marathon race. The relationship 
between finish-time and post-marathon changes in hsCRP and COMP suggests that 
being well-trained and hence performing better at a marathon results in diminished 
inflammatory reaction and faster recovery of cartilage after the race. However, to date 
the long-term effects of marathon running in heavier persons is unknown. Moreover, the 
importance of load-induced changes in COMP for long-term cartilage health in healthy 
persons and the potential development of osteoarthritis is still poorly understood. 
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Tables 
Table 1. Demographics of the participants of this study at baseline and after a 10-
week running training. 
Parameter Baseline After 10-week 
running training 
P-value 
Age (years) 40.0 
[38.2; 41.8] 
  
Height (cm) 180.8 
[178.8; 182.8] 
  
Body mass (kg) 83.6 
[79.4; 87.8] 
82.3 
[78.2; 86.5] 
<.001 
BMI (kg/m2) 25.5 
[24.5; 26.5] 
25.0 
[24.0; 26.1] 
<.001 
Body fat (%) 18.2 
[16.2; 20.3] 
16.2 
[14.4; 18.0] 
<.001 
Waist circumference 
(cm) 
91.0 
[87.5; 94.5] 
89.1 
[85.8; 92.4] 
.001 
Training distance 
(km/week) 
 43.5 
[38.8; 48.3] 
 
Marathon finishing time 
(min) 
 247 
[235; 258] 
 
Tertile groups marathon 
finishing time (min) 
fast  
middle 
slow 
  
 
<228 
228 to 261 
>261 
 
Mean [95% confidence interval] are given for all parameters. BMI and performance 
parameters are given for the beginning and end of a 10-week running training program. 
BMI – body mass index; P-values are provided for Student t-test for dependent 
measures comparing values at the beginning and the end of a 10-week training program. 
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Table 2. Statistical results of the generalized linear models. 
Factor F-value P-value Observed power 
IL-6    
time 19.583 <0.001 1.000 
time × BMI 0.035 0.991 0.056 
time × finish time 0.485 0.693 0.146 
TNF-α    
time 0.223 0.880 0.091 
time × BMI 0.238 0.869 0.094 
time × finish time 0.093 0.964 0.066 
hsCRP    
time 5.025 0.003 0.908 
time × BMI 0.410 0.746 0.129 
time × finish time 6.699 <0.001 0.971 
COMP    
time 6.287 0.001 0.962 
time × BMI 0.280 0.840 0.103 
time × finish time 9.277 <0.001 0.996 
Generalized linear models were used for detecting changes in serum biomarker 
concentrations over time with covariates BMI and marathon finish time. Significant 
differences of the generalized linear model with factor time and covariates BMI and 
marathon finish time are shown as bold numbers (P<0.001). IL-6 – interleukin 6; TNF-
α – tumor necrosis factor α; hsCRP – high sensitivity C-reactive protein; COMP – 
cartilage oligomeric matrix protein; BMI – body mass index. 
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Table 3. Statistical results of the linear regression models. 
Model Coefficient Standard error t-Statistic Probability R2 
hsCRP      
Constant 
Finishing time 
-1.592 
0.013 
0.744 
0.003 
-2.139 
4.234 
0.039 
<0.001 
 
0.320 
COMP      
Constant 
Finishing time 
-13.330 
0.055 
3.349 
0.013 
-3.980 
4.134 
<0.001 
<0.001 
 
0.284 
Linear regression models were used for detecting the effects of BMI and marathon 
finishing times on changes in biomarkers from immediately after to 24 hours after the 
marathon race. hsCRP – high-sensitivity C-reactive protein; COMP – cartilage 
oligomeric matrix protein. 
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FIGURE LEGENDS 
Figure 1. Illustration of the study protocol. 
The study protocol involved blood samples before and after a 10-week endurance 
training and a marathon race. 
 
Figure 2. Changes in IL-6 and TNF-α serum concentration over time. 
IL-6 and TNF-α serum concentrations at baseline, after a 10-week running training 
program (before marathon race) and immediately and 24 hours after a marathon race. 
Small figures show individual changes in concentrations from before to after the 
marathon race or from immediately to 24 hours after a marathon race, respectively. 
Horizontal bars indicate significant differences between time points (posthoc tests: 
repeated measured t-tests, P<0.005). 
 
Figure 3. Changes in hsCRP and COMP serum concentration over time. 
hsCRP and COMP serum concentrations at baseline, after a 10-week running training 
program (before marathon race) and immediately and 24 hours after a marathon race. 
Small figures show individual changes in concentrations from before to after the 
marathon race or from immediately to 24 hours after a marathon race, respectively. 
Horizontal bars indicate significant differences between time points (posthoc tests: 
repeated measured t-tests, P<0.005). 
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Figure 4. Association of follow-up changes in hsCRP and COMP and marathon 
performance. 
Relationship between mean (standard error) changes in hsCRP and COMP from 
immediately to 24 hours after a marathon race depending on marathon finishing time 
tertile groups. 
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